Surface chemical and physical modification in stent technology for the treatment of coronary artery disease

Feroze Nazneen1, Grégoire Herzog, Damien W M Arrigan

  • 1Tyndall National Institute, Life Sciences Interface, University College Cork, Lee Maltings, Cork, Ireland.

Insights

Coronary artery disease (CAD) treatments like stenting can be improved by modifying stent surfaces. Research explores chemical and physical surface changes to enhance compatibility and reduce complications.

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Research
  • Materials Science

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality worldwide, often treated with balloon angioplasty and stent implantation.
  • Stent implantation, while effective, can lead to adverse vascular responses and complications.
  • Improving stent-vascular compatibility is crucial for better patient outcomes.

Purpose of the Study:

  • To review the merits and limitations of current coronary artery disease treatments, focusing on stenting.
  • To explore research on modifying stent surfaces to improve biocompatibility and reduce pathophysiologies.
  • To discuss chemical and physical modification strategies and their impact on vascular cells.

Main Methods:

  • Review of existing literature on coronary artery disease treatments and stent surface modifications.
  • Analysis of chemical (passive and active) and physical surface modification techniques.
  • Discussion of in vitro studies on micro- and nanostructured surfaces and cellular responses.

Main Results:

  • Stent surface modification offers potential to enhance stent-vascular compatibility.
  • Both chemical and physical modifications can influence vascular cell responses.
  • Micro- and nanostructured surfaces show promise in modulating cellular behavior.

Conclusions:

  • Surface modification of coronary stents is a key research area for improving treatment efficacy.
  • Combining chemical and physical modification strategies may offer synergistic benefits.
  • Future research should focus on translating these modifications into clinical applications for better CAD management.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
281
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
199
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
181
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
200
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
637
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
191